Phi Diagnostics ApS: Financial statements 2025
CVR: 45303667
Source: annual report 2025, Danish Business Authority
20/12/2024 – 31/12/2025
Phi Diagnostics ApS (CVR 45303667) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 4,943,589 and a net result of DKK 2,152,797. Equity in the 2025 report amounted to DKK 2,222,797. The solvency ratio was 19.1%.
- Gross Profit
- DKK 4,943,589
- Profit/Loss
- DKK 2,152,797
- Equity
- DKK 2,222,797
- Total Assets
- DKK 11,625,330
- Employees
- 0
How creditworthy is Phi Diagnostics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of March 1, 2025, Kenneth Graabek Johansen is registered as director of Phi Diagnostics ApS.
As of February 27, 2025, KGJ Invest ApS is registered as an owner of Phi Diagnostics ApS with an ownership share of 10%.
As of February 27, 2025, InnoFoss Holding ApS is registered as an owner of Phi Diagnostics ApS with an ownership share of 10%.
As of February 27, 2025, Alizadeh Regenberg Holding ApS is registered as an owner of Phi Diagnostics ApS with an ownership share of 50%.
As of February 27, 2025, A. Alizadeh Holding ApS is registered as an owner of Phi Diagnostics ApS with an ownership share of 15%.
About Phi Diagnostics ApS
Phi Diagnostics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2024. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named CARE-DNA IP ApS. The management consists of Kenneth Graabek Johansen, Birgitte Regenberg and Sefa Alizadeh. The company's owners include KGJ Invest ApS, InnoFoss Holding ApS and Alizadeh Regenberg Holding ApS. In 2025, the company reported a gross profit of DKK 4,943,589 and a net result of DKK 2,152,797. Equity in the 2025 report amounted to DKK 2,222,797.